ARCHIVES

Includes 8-page Business & Regulatory Report.

This article is from The Cancer Letter archive.

Vol. 29 No. 15 | April 11, 2003

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Impeding Reagan Budget Cuts Feared By Cancer Program Advocates; DeVita Asks Parity With NIH

February 13, 1981

Critics Told To Back Waste Charges Or Shut Up

November 23, 1974

Agreement Reached On Most CCOP Issues; First RFA To Be Out March, Awards To Be Made In Fiscal 1983

January 22, 1982

Beahrs Report Urges Mammography Continuation, Says BCDDPs Effective In Detecting Early Cancer

September 17, 1977

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012